Skip to content

Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers

Urea, Phosphate and b2-Microglobulin Removal and Ease of Use: Comparing the Polyflux HD-C4 With the Polyflux 210H

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00636389
Enrollment
12
Registered
2008-03-14
Start date
2008-02-29
Completion date
2009-03-31
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Keywords

Hemodialysis, Dialysis, Renal, Dialysis, Extracorporeal, Extracorporeal Dialysis

Brief summary

The Polyflux HD-C4 (Gambro Renal Products) is a new dialyzer based on the existing Polyflux H membrane and dialyzer technology, but which achieves a performance comparable to Polyflux 210H in a significantly smaller device. The objectives of this study are: 1. To compare and contrast small and large molecule removal by the Polyflux HD-C4 and Polyflux 210H dialyzers under conditions of routine hemodialysis; and, 2. To compare and contrast the ease of use of the Polyflux HD-C4 dialyzer with that of the Polyflux 210H under conditions of routine clinical use for hemodialysis.

Interventions

DEVICEPolyflux 210H dialyzer

Three consecutive treatments with the Polyflux 210H dialyzer. All study treatments will be performed in the standard hemodialysis mode.

DEVICEPolyflux HD-C4

Three consecutive treatments with the Polyflux HD-C4 dialyzer. All study treatments will be performed in the standard hemodialysis mode.

Sponsors

Gambro Renal Products, Inc.
CollaboratorINDUSTRY
Baxter Healthcare Corporation
CollaboratorINDUSTRY
Vantive Health LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults 18 years of age or older * Stable hemodialysis prescription using Polyflux 210H or Polyflux 21R for at least 2 months prior to study enrollment * Dialyzing through a native fistula or Gore-Tex graft. * Blood access must be able to provide a blood flow rate of 400 ml/min.

Exclusion criteria

* Non-compliance with dialysis * Hematocrit less than 28% * Active Infection

Design outcomes

Primary

MeasureTime frameDescription
Comparison of Urea Removal Under Conditions of Routine Hemodialysis.2 weeks = duration required for each subject to complete 6 consecutive dialysis treatmentsUrea removal is correlated with successful clinical outcomes. Kt/V is a way of measuring the delivered dose of dialysis where K=clearance of urea, t=treatment time and V=volume of body water. Single-pool (sp) Kt/V assumes that urea is removed from a single compartment in the human body during dialysis. However, because there are multiple compartments in the human body, rebound occurs following hemodialysis which lowers the Kt/V. Equilibrated (e) Kt/V is an equation that has been devised to predict the amount of rebound based on the ratio of K/V. Outcomes are posted for both spKt/V and eKt/V.
A Comparison of Pre- to Post-dialysis Reduction of Small and Large Molecules Under Conditions of Routine Hemodialysis.2 weeks = duration required for each subject to complete 6 consecutive dialysis treatmentsOverall removal of urea, phosphorus and β2-microglobulin was determined from the pre- to post-dialysis change in plasma concentration and from the amount of solute recovered in the dialysate. This outcome measure is reported as the percentage of pre- to post-dialysis reduction of urea, phosphorus and β2-microglobulin.

Secondary

MeasureTime frameDescription
Comparison of Dialyzer Ease of Use Between the Polyflux HD-C4 Dialyzer and the Polyflux 210H2 weeks = duration required for each subject to complete 6 consecutive dialysis treatmentsAssessment of blood side priming: 1=Very Easy 2=Acceptable 3=Difficult 4=Very Difficult / Assessment of dialysate side priming: 1=Perfect 2=Acceptable 3= Not Acceptable / Appearance of dialyzer fibers: 1=Very Good 2=Good 3=Poor 4=Very Poor / Appearance of dialyzer arterial header: 1=Very Good 2=Good 3=Poor 4=Very Poor / Appearance of venous header: 1=Very Good 2=Good 3=Poor 4=Very Poor /

Countries

United States

Participant flow

Participants by arm

ArmCount
All Study Participants12
Total12

Baseline characteristics

CharacteristicAll Study Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
12 Participants
Age, Continuous50.2 years
STANDARD_DEVIATION 9.1
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 70 / 5
serious
Total, serious adverse events
0 / 70 / 5

Outcome results

Primary

A Comparison of Pre- to Post-dialysis Reduction of Small and Large Molecules Under Conditions of Routine Hemodialysis.

Overall removal of urea, phosphorus and β2-microglobulin was determined from the pre- to post-dialysis change in plasma concentration and from the amount of solute recovered in the dialysate. This outcome measure is reported as the percentage of pre- to post-dialysis reduction of urea, phosphorus and β2-microglobulin.

Time frame: 2 weeks = duration required for each subject to complete 6 consecutive dialysis treatments

ArmMeasureGroupValue (MEAN)Dispersion
HD-C4A Comparison of Pre- to Post-dialysis Reduction of Small and Large Molecules Under Conditions of Routine Hemodialysis.Urea Pre- to post-dialysis reduction (%)74 Percentage of reductionStandard Deviation 6
HD-C4A Comparison of Pre- to Post-dialysis Reduction of Small and Large Molecules Under Conditions of Routine Hemodialysis.Phosphorus Pre- to post-dialysis reduction (%)61 Percentage of reductionStandard Deviation 9
HD-C4A Comparison of Pre- to Post-dialysis Reduction of Small and Large Molecules Under Conditions of Routine Hemodialysis.b2-microglobulin Pre- to post-dialysis reduct (%)52 Percentage of reductionStandard Deviation 12
210HA Comparison of Pre- to Post-dialysis Reduction of Small and Large Molecules Under Conditions of Routine Hemodialysis.Urea Pre- to post-dialysis reduction (%)74 Percentage of reductionStandard Deviation 5
210HA Comparison of Pre- to Post-dialysis Reduction of Small and Large Molecules Under Conditions of Routine Hemodialysis.Phosphorus Pre- to post-dialysis reduction (%)60 Percentage of reductionStandard Deviation 17
210HA Comparison of Pre- to Post-dialysis Reduction of Small and Large Molecules Under Conditions of Routine Hemodialysis.b2-microglobulin Pre- to post-dialysis reduct (%)58 Percentage of reductionStandard Deviation 8
Primary

Comparison of Urea Removal Under Conditions of Routine Hemodialysis.

Urea removal is correlated with successful clinical outcomes. Kt/V is a way of measuring the delivered dose of dialysis where K=clearance of urea, t=treatment time and V=volume of body water. Single-pool (sp) Kt/V assumes that urea is removed from a single compartment in the human body during dialysis. However, because there are multiple compartments in the human body, rebound occurs following hemodialysis which lowers the Kt/V. Equilibrated (e) Kt/V is an equation that has been devised to predict the amount of rebound based on the ratio of K/V. Outcomes are posted for both spKt/V and eKt/V.

Time frame: 2 weeks = duration required for each subject to complete 6 consecutive dialysis treatments

ArmMeasureGroupValue (MEAN)Dispersion
HD-C4Comparison of Urea Removal Under Conditions of Routine Hemodialysis.Single-pool Kt/V Urea1.64 ratioStandard Deviation 0.26
HD-C4Comparison of Urea Removal Under Conditions of Routine Hemodialysis.Equilibrated Kt/V1.42 ratioStandard Deviation 0.22
210HComparison of Urea Removal Under Conditions of Routine Hemodialysis.Single-pool Kt/V Urea1.61 ratioStandard Deviation 0.24
210HComparison of Urea Removal Under Conditions of Routine Hemodialysis.Equilibrated Kt/V1.40 ratioStandard Deviation 0.22
Secondary

Comparison of Dialyzer Ease of Use Between the Polyflux HD-C4 Dialyzer and the Polyflux 210H

Assessment of blood side priming: 1=Very Easy 2=Acceptable 3=Difficult 4=Very Difficult / Assessment of dialysate side priming: 1=Perfect 2=Acceptable 3= Not Acceptable / Appearance of dialyzer fibers: 1=Very Good 2=Good 3=Poor 4=Very Poor / Appearance of dialyzer arterial header: 1=Very Good 2=Good 3=Poor 4=Very Poor / Appearance of venous header: 1=Very Good 2=Good 3=Poor 4=Very Poor /

Time frame: 2 weeks = duration required for each subject to complete 6 consecutive dialysis treatments

Population: Each of the 12 subjects underwent three consecutive treatments with the HD-C4 and three consecutive treatments with the Polyflux 210H.

ArmMeasureGroupValue (MEAN)Dispersion
HD-C4Comparison of Dialyzer Ease of Use Between the Polyflux HD-C4 Dialyzer and the Polyflux 210HPriming of dialysate compartment1.36 Units on a Scale 1 = BestStandard Deviation 0.49
HD-C4Comparison of Dialyzer Ease of Use Between the Polyflux HD-C4 Dialyzer and the Polyflux 210HAppearance of arterial header1.61 Units on a Scale 1 = BestStandard Deviation 0.55
HD-C4Comparison of Dialyzer Ease of Use Between the Polyflux HD-C4 Dialyzer and the Polyflux 210HAppearance of fibers1.42 Units on a Scale 1 = BestStandard Deviation 0.55
HD-C4Comparison of Dialyzer Ease of Use Between the Polyflux HD-C4 Dialyzer and the Polyflux 210HAppearance of venous header1.57 Units on a Scale 1 = BestStandard Deviation 0.74
HD-C4Comparison of Dialyzer Ease of Use Between the Polyflux HD-C4 Dialyzer and the Polyflux 210HPriming of blood compartment1.19 Units on a Scale 1 = BestStandard Deviation 0.4
210HComparison of Dialyzer Ease of Use Between the Polyflux HD-C4 Dialyzer and the Polyflux 210HAppearance of venous header1.77 Units on a Scale 1 = BestStandard Deviation 0.55
210HComparison of Dialyzer Ease of Use Between the Polyflux HD-C4 Dialyzer and the Polyflux 210HPriming of blood compartment1.47 Units on a Scale 1 = BestStandard Deviation 0.51
210HComparison of Dialyzer Ease of Use Between the Polyflux HD-C4 Dialyzer and the Polyflux 210HPriming of dialysate compartment1.51 Units on a Scale 1 = BestStandard Deviation 0.51
210HComparison of Dialyzer Ease of Use Between the Polyflux HD-C4 Dialyzer and the Polyflux 210HAppearance of fibers1.78 Units on a Scale 1 = BestStandard Deviation 0.64
210HComparison of Dialyzer Ease of Use Between the Polyflux HD-C4 Dialyzer and the Polyflux 210HAppearance of arterial header1.72 Units on a Scale 1 = BestStandard Deviation 0.51

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026